Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

A red quarter of a circle with the words 'The Quarter Mark' beside it. A year-long series looking back on the most significant moments of the past 25 years, how they changed our world, and how they ...

The colonies of Escherichia coli sitting in this petri dish become pathogenic when they carry Shiga toxin genes. Credit: Shutterstock “We’re essentially converting a pathogenic strain into a ...

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they'd stumbled upon a revolutionary tool researchers could ...

Another day, another CRISPR issue to worry about. Shares of gene-editing biotechs CRISPR Therapeutics (NASDAQ: CRSP), Editas Medicine (NASDAQ: EDIT), and Intellia Therapeutics (NASDAQ: NTLA) sank on ...

CRISPR Therapeutics' Casgevy, the first CRISPR/Cas9 gene editing therapy, shows promising results in treating Sickle Cell Disease and beta thalassemia but faces challenges in patient adoption and cost ...

It's been called the biggest biotech discovery of the century. And one company claims the largest market cap of any biotech focused on this major breakthrough. *As of Jul. 12, 2018. Data source: Yahoo ...

A 'loopy' discovery in bacteria is raising fundamental questions about the makeup of our own genome -- and revealing a potential wellspring of material for new genetic therapies. A "loopy" discovery ...

Scientists say they have shed new light on how bacteria protect themselves from certain phage invaders -- by seizing genetic material from weakened, dormant phages and using it to 'vaccinate' ...

The new research focused on a particular protein used by bacteriophages (representational). As the globe faces a rise in antibiotic-resistant bacteria – making traditional antibiotics ineffective – ...